Digital health startup Klineo announced that it has raised €2 million to improve equity of access to clinical trials. Its AI-based platform connects doctors and patients directly with relevant trials in less than a minute. Fast and intuitive, this solution democratizes access to new treatments for patients. This funding will enable Klineo to expand its solution to all types of cancer, in a context where the number of patients and clinical trials are experiencing significant growth.
Stefano De Marzo is the Head of News at EU-Startups, a leading online publication covering the European startup ecosystem. With his extensive experience in the field, Stefano writes articles that highlight the latest funding rounds, investments, and innovations within the startup industry, focusing on companies across Europe. His work has also been featured in other notable publications such as Novobrief, Sifted, and 150sec.com.